New research highlights a significant link between metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

Often symptomless, fatty liver disease is becoming a leading cause of liver cancer. Learn the role of daily habits, early ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

A new analysis from the Chile BiLS study evaluated the reliability of ultrasound imaging for diagnosing SLD in a high-risk ...

New European guidelines redefine Metabolic dysfunction-associated steatotic liver disease (MASLD) care, offering clearer ...

Fatty liver disease symptoms change as the disease progresses. You may not have symptoms early on, but upper-right abdominal ...

One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague symptoms like constant fatigue or nausea.

Discover the alarming rise of Non-alcoholic fatty liver disease (NAFLD) in children and learn key preventive measures from ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of hepatic fibrosis, yet its prevalence in asymptomatic ...

China: A large-scale U.S. analysis has revealed that people living with both type 2 diabetes (T2DM) and chronic kidney ...